|
NZ280610A
(en)
*
|
1994-12-29 |
1997-08-22 |
Mcneil Ppc Inc |
Soft gelatin-like pharmaceutical carrier: gelled polyethylene glycol and dispersed active agent
|
|
US5660859A
(en)
*
|
1994-12-29 |
1997-08-26 |
Mcneil-Ppc, Inc. |
Gelling agent for polyethylene glycol
|
|
US5919481A
(en)
*
|
1996-06-28 |
1999-07-06 |
Ncneil-Ppc, Inc. |
Fill material for soft gelatin pharmaceutical dosage form
|
|
US5908636A
(en)
*
|
1996-06-28 |
1999-06-01 |
Mcneil-Ppc, Inc. |
Fill material for soft gelatin pharmaceutical dosage form containing an antiflatulent
|
|
US6024980A
(en)
*
|
1996-06-28 |
2000-02-15 |
Mcneil-Ppc, Inc. |
Multiphase soft gelatin dosage form
|
|
FR2787715B1
(fr)
*
|
1998-12-23 |
2002-05-10 |
Synthelabo |
Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables
|
|
BR0205722A
(pt)
|
2001-07-06 |
2005-04-05 |
Penwest Pharmaceuticals Compan |
Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
|
|
US8329216B2
(en)
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
|
CN1551770A
(zh)
|
2001-07-06 |
2004-12-01 |
������ҩ������˾ |
羟吗啡酮控释制剂
|
|
WO2003013481A1
(en)
*
|
2001-08-03 |
2003-02-20 |
Bakulesh Mafatlal Khamar |
The process of manufacturing pharmaceutical composition with increased content of poorly soluble pharmaceutical ingredients
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
US20030068276A1
(en)
|
2001-09-17 |
2003-04-10 |
Lyn Hughes |
Dosage forms
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
CN101797221B
(zh)
|
2002-12-13 |
2013-06-12 |
杜雷科特公司 |
包含高粘度液体载体材料的口服递药系统
|
|
WO2004112756A1
(en)
|
2003-06-26 |
2004-12-29 |
Isa Odidi |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
CA2569958C
(en)
|
2004-06-12 |
2016-03-22 |
Jane C. Hirsh |
Abuse-deterrent drug formulations
|
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
|
AU2005287175B2
(en)
|
2004-09-17 |
2011-12-01 |
Durect Corporation |
Sustained local anesthetic composition containing preferably a sugar ester such as SAIB
|
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
|
CN101453993A
(zh)
|
2006-04-03 |
2009-06-10 |
伊萨·奥迪迪 |
含有机溶胶涂层的受控释放递送物件
|
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
EP2117521B1
(en)
|
2006-11-03 |
2012-06-27 |
Durect Corporation |
Transdermal delivery systems comprising bupivacaine
|
|
JP2011506319A
(ja)
|
2007-12-06 |
2011-03-03 |
デュレクト コーポレーション |
疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
|
|
CA2713128C
(en)
|
2008-01-25 |
2016-04-05 |
Gruenenthal Gmbh |
Pharmaceutical dosage form
|
|
PT2273983T
(pt)
|
2008-05-09 |
2016-10-28 |
Gruenenthal Gmbh |
Processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob utilização de uma etapa de congelamento por atomização
|
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
|
BR112012001547A2
(pt)
|
2009-07-22 |
2016-03-08 |
Gruenenthal Gmbh |
forma de dosagem farmacêutica extrusada por fusão a quente
|
|
PE20120572A1
(es)
|
2009-07-22 |
2012-06-06 |
Gruenenthal Chemie |
Forma de dosificacion de oxidacion estabilizada resistente a la manipulacion
|
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
MX2013002377A
(es)
|
2010-09-02 |
2013-04-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
|
|
AU2011297892B2
(en)
|
2010-09-02 |
2014-05-29 |
Grunenthal Gmbh |
Tamper resistant dosage form comprising an anionic polymer
|
|
MX367010B
(es)
|
2010-12-22 |
2019-08-02 |
Purdue Pharma Lp |
Formas de dosis de liberacion controlada encerradas resistentes a manipulaciones indebidas.
|
|
PH12013501345A1
(en)
|
2010-12-23 |
2022-10-24 |
Purdue Pharma Lp |
Tamper resistant solid oral dosage forms
|
|
MX348054B
(es)
|
2011-07-29 |
2017-05-25 |
Gruenenthal Gmbh |
Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco.
|
|
NO2736495T3
(no)
|
2011-07-29 |
2018-01-20 |
|
|
|
CA2864949A1
(en)
|
2012-02-28 |
2013-09-06 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
|
PT2838512T
(pt)
|
2012-04-18 |
2018-11-09 |
Gruenenthal Gmbh |
Forma farmacêutica resistente à adulteração e resistente à libertação inesperada de alta quantidade (dose-dumping)
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
|
CN105120846B
(zh)
|
2013-02-05 |
2019-10-18 |
普渡制药公司 |
抗篡改的药物制剂
|
|
US10420729B2
(en)
|
2013-03-15 |
2019-09-24 |
R.P. Scherer Technologies, Llc |
Abuse resistant capsule
|
|
JP2016515523A
(ja)
|
2013-03-15 |
2016-05-30 |
デュレクト コーポレーション |
溶解変動性を低減させるためのレオロジー改質剤を有する組成物
|
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
WO2014191397A1
(en)
|
2013-05-29 |
2014-12-04 |
Grünenthal GmbH |
Tamper-resistant dosage form containing one or more particles
|
|
JP6466417B2
(ja)
|
2013-05-29 |
2019-02-06 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
|
|
BR112016000194A8
(pt)
|
2013-07-12 |
2019-12-31 |
Gruenenthal Gmbh |
forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
|
|
US10195153B2
(en)
|
2013-08-12 |
2019-02-05 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded immediate release abuse deterrent pill
|
|
MX371372B
(es)
|
2013-11-26 |
2020-01-28 |
Gruenenthal Gmbh |
Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
|
|
US10172797B2
(en)
|
2013-12-17 |
2019-01-08 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
US9492444B2
(en)
|
2013-12-17 |
2016-11-15 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
CN106572980A
(zh)
|
2014-05-12 |
2017-04-19 |
格吕伦塔尔有限公司 |
包含他喷他多的防篡改即释胶囊制剂
|
|
MX2016015417A
(es)
|
2014-05-26 |
2017-02-22 |
Gruenenthal Gmbh |
Multiparticulas protegidas contra vertido de dosis etanolico.
|
|
GB201409471D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
US9707184B2
(en)
|
2014-07-17 |
2017-07-18 |
Pharmaceutical Manufacturing Research Services, Inc. |
Immediate release abuse deterrent liquid fill dosage form
|
|
US20160106737A1
(en)
|
2014-10-20 |
2016-04-21 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extended Release Abuse Deterrent Liquid Fill Dosage Form
|
|
US9908976B2
(en)
*
|
2015-03-18 |
2018-03-06 |
Psmg, Llc |
Stable polyethylene glycol particle dispersions and methods for forming the stable dispersions
|
|
AU2016251854A1
(en)
|
2015-04-24 |
2017-10-19 |
Grunenthal Gmbh |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|
|
WO2017205939A1
(en)
*
|
2016-06-03 |
2017-12-07 |
Indigo Ridge Pty Ltd |
Vitamin d formulations and therapeutic uses thereof
|
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
|
AU2017292791B2
(en)
|
2016-07-06 |
2023-05-25 |
Orient Pharma Co., Ltd. |
Oral dosage form with drug composition, barrier layer and drug layer
|
|
CA3040155C
(en)
|
2016-10-11 |
2024-01-16 |
Euro-Celtique S.A. |
Compound for use in the treatment of hodgkin lymphoma
|
|
GB201709403D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating sarcoma
|
|
AU2019402158B2
(en)
|
2018-12-18 |
2025-07-03 |
Mundipharma International Corporation Limited |
Compounds for treating lymphoma or a T-cell malignant disease
|
|
CA3167217A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|
|
CA3203561A1
(en)
|
2021-01-12 |
2022-07-21 |
Adrian Neil Verity |
Sustained release drug delivery systems and related methods
|